Literature DB >> 12729075

Hepatitis C virus transmission from an antibody-negative organ and tissue donor--United States, 2000-2002.

.   

Abstract

In June 2002, a physician reported to the Oregon Department of Human Services (DHS) a case of acute hepatitis C in a patient who had received a patellar tendon with bone allograft from a donor approximately 6 weeks before onset of illness. At the time of the donor's death in October 2000, his serum had no detectable antibody to hepatitis C virus (anti-HCV). The ensuing investigation conducted by CDC and DHS confirmed that the donor, although anti-HCV-negative, was HCV RNA-positive and the probable source of HCV infection for at least eight organ and tissue recipients. This report summarizes the preliminary results of the investigation. Although transmission from anti-HCV-negative tissue donors probably is rare, determining the frequency of transplantations from such donors and the risk for transmitting HCV to recipients is important in evaluating whether additional prevention measures are warranted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729075

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  14 in total

1.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

2.  [Musculoskeletal tissue banks. Legal foundations and graft safety].

Authors:  A Prub; B-D Katthagen
Journal:  Orthopade       Date:  2008-08       Impact factor: 1.087

3.  Reducing allograft contamination and disease transmission: intraosseous temperatures of femoral head allografts during autoclaving.

Authors:  Chay-You Ang; Andy Khye-Soon Yew; Darren Keng-Jin Tay; Shi-Lu Chia; Seng-Jin Yeo; Ngai-Nung Lo; Pak-Lin Chin
Journal:  Singapore Med J       Date:  2014-10       Impact factor: 1.858

Review 4.  [Prevention of infections due to musculoskeletal allografts].

Authors:  A Pruß
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

Review 5.  Health care-associated hepatitis C virus infection.

Authors:  Bruno Pozzetto; Meriam Memmi; Olivier Garraud; Xavier Roblin; Philippe Berthelot
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

6.  Radioprotectant and radiosensitizer effects on sterility of gamma-irradiated bone.

Authors:  Seema A Kattaya; Ozan Akkus; James Slama
Journal:  Clin Orthop Relat Res       Date:  2008-05-17       Impact factor: 4.176

7.  Remodeling of ACL allografts is inhibited by peracetic acid sterilization.

Authors:  Sven U Scheffler; Johannes Gonnermann; Julia Kamp; Dorothea Przybilla; Axel Pruss
Journal:  Clin Orthop Relat Res       Date:  2008-05-20       Impact factor: 4.176

8.  Algorithms for the Testing of Tissue Donors for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus.

Authors:  Axel Pruß; Akila Chandrasekar; Jacinto Sánchez-Ibáñez; Sophie Lucas-Samuel; Ulrich Kalus; Holger F Rabenau
Journal:  Transfus Med Hemother       Date:  2020-12-22       Impact factor: 3.747

9.  Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017.

Authors:  Danae Bixler; Pallavi Annambholta; Winston E Abara; Melissa G Collier; Jefferson Jones; Tonya Mixson-Hayden; Sridhar V Basavaraju; Sumathi Ramachandran; Saleem Kamili; Anne Moorman
Journal:  Am J Transplant       Date:  2019-04-29       Impact factor: 9.369

10.  In vitro testing of femoral impaction grafting with porous titanium particles: a pilot study.

Authors:  René Aquarius; Luc Walschot; Pieter Buma; Berend Willem Schreurs; Nico Verdonschot
Journal:  Clin Orthop Relat Res       Date:  2009-01-13       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.